Ayurvedic Treatment Package in Plaque Psoriasis
Launched by UNIVERSITÄT DUISBURG-ESSEN · Oct 29, 2019
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with psoriasis having age 18 years or more
- • Patients with moderate-to-severe plaque psoriasis with a PASI score of 12 or higher
- • Psoriasis diagnosed 6 months or more before study entry
- • Those who are poorly controlled based on physicians assessment with topical treatments, phototherapy, systemic therapy, or a combination of these therapies.
- • Participants who have given informed consent.
- Exclusion Criteria:
- • Participants with other systemic illnesses
- • Lactating and pregnant mothers.
- • Alcohol dependence/Narcotic dependence /Steroid dependence
- • In the judgment of the investigator, unable or unwilling to follow the protocol and instructions
About Universität Duisburg Essen
The Universität Duisburg-Essen is a prominent academic institution in Germany, renowned for its commitment to research and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, the university leverages its interdisciplinary expertise and state-of-the-art facilities to advance clinical research initiatives. With a focus on improving patient outcomes, the university actively collaborates with healthcare professionals, industry partners, and regulatory bodies to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Through its dedication to enhancing clinical knowledge and fostering new therapeutic approaches, Universität Duisburg-Essen plays a pivotal role in the evolution of modern healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shoranur, Kerala, India
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials